Global and United States Oncolytic Virus Immunotherapy Market Report & Forecast 2023-2028

Report ID: 1861498 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Oncolytic Virus Immunotherapy Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Oncolytic Virus Immunotherapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Oncolytic Virus Immunotherapy Market Size for the Year 2017-2028
        1.2.2 Global Oncolytic Virus Immunotherapy Market Size for the Year 2017-2028
    1.3 Oncolytic Virus Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Oncolytic Virus Immunotherapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Oncolytic Virus Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Oncolytic Virus Immunotherapy Market Dynamics
        1.4.1 Oncolytic Virus Immunotherapy Industry Trends
        1.4.2 Oncolytic Virus Immunotherapy Market Drivers
        1.4.3 Oncolytic Virus Immunotherapy Market Challenges
        1.4.4 Oncolytic Virus Immunotherapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Oncolytic Virus Immunotherapy by Type
    2.1 Oncolytic Virus Immunotherapy Market Segment by Type
        2.1.1 Engineering Oncolytic Viruses
        2.1.2 Wild-Type Oncolytic Viruses
    2.2 Global Oncolytic Virus Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global Oncolytic Virus Immunotherapy Market Size by Type (2017-2028)
    2.4 United States Oncolytic Virus Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States Oncolytic Virus Immunotherapy Market Size by Type (2017-2028)
3 Oncolytic Virus Immunotherapy by Application
    3.1 Oncolytic Virus Immunotherapy Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Ambulatory Surgical Centers
    3.2 Global Oncolytic Virus Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global Oncolytic Virus Immunotherapy Market Size by Application (2017-2028)
    3.4 United States Oncolytic Virus Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States Oncolytic Virus Immunotherapy Market Size by Application (2017-2028)
4 Global Oncolytic Virus Immunotherapy Competitor Landscape by Company
    4.1 Global Oncolytic Virus Immunotherapy Market Size by Company
        4.1.1 Top Global Oncolytic Virus Immunotherapy Companies Ranked by Revenue (2021)
        4.1.2 Global Oncolytic Virus Immunotherapy Revenue by Player (2017-2022)
    4.2 Global Oncolytic Virus Immunotherapy Concentration Ratio (CR)
        4.2.1 Oncolytic Virus Immunotherapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Oncolytic Virus Immunotherapy in 2021
        4.2.3 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Oncolytic Virus Immunotherapy Headquarters, Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Oncolytic Virus Immunotherapy Headquarters and Area Served
        4.3.2 Global Oncolytic Virus Immunotherapy Companies Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Oncolytic Virus Immunotherapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Oncolytic Virus Immunotherapy Market Size by Company
        4.5.1 Top Oncolytic Virus Immunotherapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Oncolytic Virus Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Oncolytic Virus Immunotherapy Market Size by Region
    5.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Oncolytic Virus Immunotherapy Market Size by Region (2017-2028)
        5.2.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2017-2022
        5.2.2 Global Oncolytic Virus Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
        6.1.2 North America Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
        6.3.2 Europe Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Merck
        7.1.1 Merck Company Details
        7.1.2 Merck Business Overview
        7.1.3 Merck Oncolytic Virus Immunotherapy Introduction
        7.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.1.5 Merck Recent Development
    7.2 Amgen
        7.2.1 Amgen Company Details
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
        7.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.2.5 Amgen Recent Development
    7.3 TILT Biotherapeutics
        7.3.1 TILT Biotherapeutics Company Details
        7.3.2 TILT Biotherapeutics Business Overview
        7.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
        7.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.3.5 TILT Biotherapeutics Recent Development
    7.4 Oncorus
        7.4.1 Oncorus Company Details
        7.4.2 Oncorus Business Overview
        7.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
        7.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.4.5 Oncorus Recent Development
    7.5 Sorrento Therapeutics
        7.5.1 Sorrento Therapeutics Company Details
        7.5.2 Sorrento Therapeutics Business Overview
        7.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
        7.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.5.5 Sorrento Therapeutics Recent Development
    7.6 Shanghai Sunway Biotech
        7.6.1 Shanghai Sunway Biotech Company Details
        7.6.2 Shanghai Sunway Biotech Business Overview
        7.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
        7.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        7.6.5 Shanghai Sunway Biotech Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Oncolytic Virus Immunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Oncolytic Virus Immunotherapy Market Trends
    Table 3. Oncolytic Virus Immunotherapy Market Drivers
    Table 4. Oncolytic Virus Immunotherapy Market Challenges
    Table 5. Oncolytic Virus Immunotherapy Market Restraints
    Table 6. Global Oncolytic Virus Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oncolytic Virus Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oncolytic Virus Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oncolytic Virus Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oncolytic Virus Immunotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oncolytic Virus Immunotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Oncolytic Virus Immunotherapy Revenue Share by Player, 2017-2022
    Table 13. Global Oncolytic Virus Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oncolytic Virus Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2021)
    Table 15. Top Players of Oncolytic Virus Immunotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Oncolytic Virus Immunotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Oncolytic Virus Immunotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Oncolytic Virus Immunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Oncolytic Virus Immunotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Oncolytic Virus Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Oncolytic Virus Immunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Oncolytic Virus Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Oncolytic Virus Immunotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Oncolytic Virus Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Oncolytic Virus Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Oncolytic Virus Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Merck Company Details
    Table 31. Merck Business Overview
    Table 32. Merck Oncolytic Virus Immunotherapy Product
    Table 33. Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 34. Merck Recent Development
    Table 35. Amgen Company Details
    Table 36. Amgen Business Overview
    Table 37. Amgen Oncolytic Virus Immunotherapy Product
    Table 38. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 39. Amgen Recent Development
    Table 40. TILT Biotherapeutics Company Details
    Table 41. TILT Biotherapeutics Business Overview
    Table 42. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
    Table 43. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 44. TILT Biotherapeutics Recent Development
    Table 45. Oncorus Company Details
    Table 46. Oncorus Business Overview
    Table 47. Oncorus Oncolytic Virus Immunotherapy Product
    Table 48. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 49. Oncorus Recent Development
    Table 50. Sorrento Therapeutics Company Details
    Table 51. Sorrento Therapeutics Business Overview
    Table 52. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
    Table 53. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 54. Sorrento Therapeutics Recent Development
    Table 55. Shanghai Sunway Biotech Company Details
    Table 56. Shanghai Sunway Biotech Business Overview
    Table 57. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
    Table 58. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 59. Shanghai Sunway Biotech Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncolytic Virus Immunotherapy Product Picture
    Figure 2. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oncolytic Virus Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Oncolytic Virus Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Oncolytic Virus Immunotherapy Market Share in Global 2017-2028
    Figure 7. Oncolytic Virus Immunotherapy Report Years Considered
    Figure 8. Product Picture of Engineering Oncolytic Viruses
    Figure 9. Product Picture of Wild-Type Oncolytic Viruses
    Figure 10. Global Oncolytic Virus Immunotherapy Market Share by Type in 2022 & 2028
    Figure 11. Global Oncolytic Virus Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Oncolytic Virus Immunotherapy Market Share by Type (2017-2028)
    Figure 13. United States Oncolytic Virus Immunotherapy Market Share by Type in 2022 & 2028
    Figure 14. United States Oncolytic Virus Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Oncolytic Virus Immunotherapy Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Ambulatory Surgical Centers
    Figure 19. Global Oncolytic Virus Immunotherapy Market Share by Application in 2022 & 2028
    Figure 20. Global Oncolytic Virus Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Oncolytic Virus Immunotherapy Market Share by Application (2017-2028)
    Figure 22. United States Oncolytic Virus Immunotherapy Market Share by Application in 2022 & 2028
    Figure 23. United States Oncolytic Virus Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Oncolytic Virus Immunotherapy Market Share by Application (2017-2028)
    Figure 25. North America Oncolytic Virus Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Oncolytic Virus Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Oncolytic Virus Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Oncolytic Virus Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Oncolytic Virus Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 54. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 55. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 56. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 57. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 58. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Frequently Asked Questions
Oncolytic Virus Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncolytic Virus Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncolytic Virus Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Online Apparel

Online Apparel market is segmented by region (country), players, by Type and by Application. Play ... Read More

Nursing Clogs

Nursing Clogs market is segmented by region (country), players, by Type and by Application. Playe ... Read More